Status:

UNKNOWN

Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries

Lead Sponsor:

Assiut University

Conditions:

Agitation, Emergence

Post Operative Pain

Eligibility:

All Genders

2-12 years

Phase:

PHASE1

Brief Summary

Effect of caudal nalbuphine on postoperative emergence agitation in pediatrics undergoing infra-umbilical surgeries and pain assessment

Eligibility Criteria

Inclusion

  • Age 2\_12 years
  • Both genders
  • ASA I\_II
  • Children undergoing infra-umbilical surgeries

Exclusion

  • Guardians refusal
  • congenital anomalies at the lower spine or meringues
  • Increased intracranial pressure
  • Skin infection at site of injection
  • Bleeding diathesis
  • Known allergy to any drugs used

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2023

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT05245721

Start Date

March 1 2022

End Date

February 1 2023

Last Update

February 18 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.